Annual EBITDA
$816.80M$17.74M+2.22%
Summary
- Current Value
- As of today, ALGN annual EBITDA is $816.80M, up +2.22% on
- Historical Performance
- ALGN annual EBITDA is down -26.54% over the past 3 years, and up +32.20% over the past 5 years
- All-Time High Comparison
- ALGN annual EBITDA is currently -26.54% below its historical high of $1.11B set on
- 3-Year Low Comparison
- ALGN annual EBITDA is +2.22% above its 3-year low of $799.06M reached on
- Sector Comparison
- ALGN annual EBITDA is higher than 93.29% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $816.80M | +2.2% | -26.5% | +32.2% | +1534.1% | |
| Quarterly EBITDA | $211.78M | +5.8% | +15.4% | +2.2% | +638.6% | |
| TTM EBITDA | $805.04M | -1.8% | -10.8% | +84.0% | +622.9% | |
| Price | $171.49 | -21.7% | -28.5% | -69.8% | +736.5% | |
| PE Ratio | 33.23 | -14.6% | -36.3% | +31.6% | +55.6% | |
| Annual Revenue | $4.00B | +3.5% | +1.2% | +66.2% | +1180.4% | |
| Annual EPS | $5.62 | -3.3% | -42.0% | +1.6% | +1348.6% | |
| Annual EBIT | $671.76M | +2.3% | -31.2% | +30.6% | +1716.6% | |
| Annual Net Income | $421.36M | -5.3% | -45.4% | -4.8% | +1447.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $816.80M | at high | |
| 5Y | $1.11B | -26.5% | |
| All | $1.11B | -26.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $799.06M | +2.2% | |
| 5Y | $503.14M | N/A | +62.3% |
| All | -$90.85M | +999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of ALGN?
As of today, ALGN annual EBITDA is $816.80M
What is 1-year change in ALGN annual EBITDA?
ALGN annual EBITDA is up +2.22% year-over-year
What is 3-year change in ALGN annual EBITDA?
ALGN annual EBITDA is down -26.54% over the past 3 years
How far is ALGN annual EBITDA from its all-time high?
ALGN annual EBITDA is currently -26.54% below its historical high of $1.11B set on December 31, 2021
How does ALGN annual EBITDA rank versus sector peers?
ALGN annual EBITDA is higher than 93.29% of companies in Healthcare sector
When is ALGN next annual earnings release?
The next annual earnings release for ALGN is on
Quarterly EBITDA
$211.78M$8.18M+4.02%
Summary
- Current Value
- As of today, ALGN quarterly EBITDA is $211.78M, up +4.02% on
- Historical Performance
- ALGN quarterly EBITDA is up +5.81% year-over-year, and up +15.40% over the past 3 years
- All-Time High Comparison
- ALGN quarterly EBITDA is currently -29.71% below its historical high of $301.30M set on
- 3-Year Low Comparison
- ALGN quarterly EBITDA is +27.90% above its 3-year low of $165.58M reached on an earlier date
- Sector Comparison
- ALGN quarterly EBITDA is higher than 92.13% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $211.78M | +4.0% | +5.8% | +15.4% | +2.2% | |
| Annual EBITDA | $816.80M | – | +2.2% | -26.5% | +32.2% | |
| TTM EBITDA | $805.04M | +1.5% | -1.8% | -10.8% | +84.0% | |
| Price | $171.49 | +32.1% | -21.7% | -28.5% | -69.8% | |
| PE Ratio | 33.23 | +32.1% | -14.6% | -36.3% | +31.6% | |
| Quarterly Revenue | $995.69M | -1.7% | +1.8% | +11.8% | +35.6% | |
| Quarterly EPS | $0.78 | -54.3% | -49.5% | -15.7% | -55.5% | |
| Quarterly EBIT | $156.06M | -4.3% | -3.9% | +8.6% | -11.9% | |
| Quarterly Net Income | $56.75M | -54.5% | -51.1% | -21.9% | -59.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $215.22M | N/A | -1.6% |
| 3Y | $218.23M | -3.0% | |
| 5Y | $301.30M | -29.7% | |
| All | $301.30M | -29.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $174.43M | +21.4% | |
| 3Y | $165.58M | N/A | +27.9% |
| 5Y | $165.58M | +27.9% | |
| All | -$43.85M | +582.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ALGN?
As of today, ALGN quarterly EBITDA is $211.78M
What is ALGN quarterly EBITDA most recent change?
ALGN quarterly EBITDA was up +4.02% on September 30, 2025
What is 1-year change in ALGN quarterly EBITDA?
ALGN quarterly EBITDA is up +5.81% year-over-year
How far is ALGN quarterly EBITDA from its all-time high?
ALGN quarterly EBITDA is currently -29.71% below its historical high of $301.30M set on June 30, 2021
How does ALGN quarterly EBITDA rank versus sector peers?
ALGN quarterly EBITDA is higher than 92.13% of companies in Healthcare sector
When is ALGN next earnings release?
The next earnings release for ALGN is on
TTM EBITDA
$805.04M$11.63M+1.47%
Summary
- Current Value
- As of today, ALGN TTM EBITDA is $805.04M, up +1.47% on
- Historical Performance
- ALGN TTM EBITDA is down -1.80% year-over-year, and down -10.75% over the past 3 years
- All-Time High Comparison
- ALGN TTM EBITDA is currently -27.55% below its historical high of $1.11B set on
- 3-Year Low Comparison
- ALGN TTM EBITDA is +8.54% above its 3-year low of $741.73M reached on
- Sector Comparison
- ALGN TTM EBITDA is higher than 92.22% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $805.04M | +1.5% | -1.8% | -10.8% | +84.0% | |
| Annual EBITDA | $816.80M | – | +2.2% | -26.5% | +32.2% | |
| Quarterly EBITDA | $211.78M | +4.0% | +5.8% | +15.4% | +2.2% | |
| Price | $171.49 | +32.1% | -21.7% | -28.5% | -69.8% | |
| PE Ratio | 33.23 | +32.1% | -14.6% | -36.3% | +31.6% | |
| TTM Revenue | $3.98B | +0.5% | +0.6% | +3.1% | +74.1% | |
| TTM EPS | $5.16 | -12.9% | -12.0% | -20.2% | -76.5% | |
| TTM EBIT | $631.46M | -1.0% | -7.1% | -15.9% | +94.2% | |
| TTM Net Income | $378.40M | -13.5% | -14.3% | -25.9% | -78.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $816.80M | N/A | -1.4% |
| 3Y | $824.22M | -2.3% | |
| 5Y | $1.11B | -27.6% | |
| All | $1.11B | -27.6% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $793.41M | +1.5% | |
| 3Y | $741.73M | +8.5% | |
| 5Y | $503.14M | N/A | +60.0% |
| All | -$106.47M | +856.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ALGN?
As of today, ALGN TTM EBITDA is $805.04M
What is ALGN TTM EBITDA most recent change?
ALGN TTM EBITDA was up +1.47% on September 30, 2025
What is 1-year change in ALGN TTM EBITDA?
ALGN TTM EBITDA is down -1.80% year-over-year
How far is ALGN TTM EBITDA from its all-time high?
ALGN TTM EBITDA is currently -27.55% below its historical high of $1.11B set on December 31, 2021
How does ALGN TTM EBITDA rank versus sector peers?
ALGN TTM EBITDA is higher than 92.22% of companies in Healthcare sector
When is ALGN next earnings release?
The next earnings release for ALGN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ALGN Official Website www.aligntech.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1097149/000109714925000075/0001097149-25-000075-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1097149/000109714925000012/0001097149-25-000012-index.htm
- ALGN Profile on Yahoo Finance finance.yahoo.com/quote/ALGN
- ALGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/algn